{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:51:29Z","timestamp":1791341489911,"version":"4.3.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["#2023-00356, #2022-01018 and #2019-02397"],"award-info":[{"award-number":["#2023-00356, #2022-01018 and #2019-02397"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Union\u2019s Horizon Europe research and innovation programme","award":["No 101053962"],"award-info":[{"award-number":["No 101053962"]}]},{"name":"Swedish State Support for Clinical Research","award":["#ALFGBG-71320"],"award-info":[{"award-number":["#ALFGBG-71320"]}]},{"DOI":"10.13039\/100002565","name":"Alzheimer\u2019s Drug Discovery Foundation","doi-asserted-by":"publisher","award":["#201809-2016862"],"award-info":[{"award-number":["#201809-2016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AD Strategic Fund and the Alzheimer\u2019s Association","award":["(#ADSF-21-831376-C, #ADSF-21-831381-C, #ADSF-21-831377-C, and #ADSF-24-1284328-C"],"award-info":[{"award-number":["(#ADSF-21-831376-C, #ADSF-21-831381-C, #ADSF-21-831377-C, and #ADSF-24-1284328-C"]}]},{"name":"European Partnership on Metrology, co-financed from the European Union\u2019s Horizon Europe Research and Innovation Programme and by the Participating States","award":["NEuroBioStand, #22HLT07"],"award-info":[{"award-number":["NEuroBioStand, #22HLT07"]}]},{"name":"Bluefield Project, Cure Alzheimer\u2019s Fund, the Olav Thon Foundation, the Erling-Persson Family Foundation, Familjen R\u00f6nstr\u00f6ms Stiftelse, Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor, Hj\u00e4rnfonden, Sweden","award":["#FO2022-0270"],"award-info":[{"award-number":["#FO2022-0270"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme under the Marie Sk\u0142odowska-Curie grant agreement","award":["No 860197"],"award-info":[{"award-number":["No 860197"]}]},{"name":"European Union Joint Programme \u2013 Neurodegenerative Disease Research","award":["JPND2021-00694"],"award-info":[{"award-number":["JPND2021-00694"]}]},{"name":"National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre, the UK Dementia Research Institute at UCL","award":["UKDRI-1003"],"award-info":[{"award-number":["UKDRI-1003"]}]},{"name":"Korea Dementia Research Project through the Korea Dementia Research Center(KDRC), funded by the Ministry of Health & Welfare and Ministry of Science and ICT","award":["RS-2020-KH106434"],"award-info":[{"award-number":["RS-2020-KH106434"]}]},{"name":"National Research Foundation of Korea(NRF) grant funded by the Korea governmen","award":["RS-2019-NR040057"],"award-info":[{"award-number":["RS-2019-NR040057"]}]},{"name":"Institute of Information & communications Technology Planning & Evaluation (IITP) grant funded by the Korea governmen","award":["RS-2021-II212068"],"award-info":[{"award-number":["RS-2021-II212068"]}]},{"name":"Future Medicine 20*30 Project of the Samsung Medical Center","award":["#SMX1250081"],"award-info":[{"award-number":["#SMX1250081"]}]},{"name":"\"Korea National Institute of Health\" research project","award":["2024-ER1003-01"],"award-info":[{"award-number":["2024-ER1003-01"]}]},{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare","award":["RS-2025-02223212"],"award-info":[{"award-number":["RS-2025-02223212"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14200-y","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T06:43:07Z","timestamp":1755758587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mapping Alzheimer\u2019s disease pathology using free water through integrated analysis of plasma biomarkers, microstructural DTI metrics, and macrostructural MRI measures"],"prefix":"10.1038","volume":"15","author":[{"given":"Bo-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihwan","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuHyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gonzalez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Pyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"14200_CR1","doi-asserted-by":"publisher","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. The Lancet vol. 397 Preprint at (2021). https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"14200_CR2","doi-asserted-by":"crossref","unstructured":"Verberk, I. M. W. et al. Combination of plasma amyloid beta(1\u201342\/1\u201340)and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimers Res. Ther 12, (2020).","DOI":"10.1186\/s13195-020-00682-7"},{"key":"14200_CR3","doi-asserted-by":"crossref","unstructured":"Palmqvist, S. et al. Discriminative accuracy of plasma Phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA J. Am. Med. Assoc. 324, (2020).","DOI":"10.1001\/jama.2020.12134"},{"key":"14200_CR4","doi-asserted-by":"crossref","unstructured":"Mattsson-Carlgren, N. et al. Soluble P\u2010tau217 reflects amyloid and Tau pathology and mediates the association of amyloid with Tau. EMBO Mol. Med 13, (2021).","DOI":"10.15252\/emmm.202114022"},{"key":"14200_CR5","doi-asserted-by":"crossref","unstructured":"Mielke, M. M. et al. Plasma and CSF neurofilament light: relation to longitudinal neuroimaging and cognitive measures. Neurology 93, (2019).","DOI":"10.1212\/WNL.0000000000007767"},{"key":"14200_CR6","doi-asserted-by":"crossref","unstructured":"Mattsson, N. et al. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol 74, (2017).","DOI":"10.1001\/jamaneurol.2016.6117"},{"key":"14200_CR7","doi-asserted-by":"crossref","unstructured":"Cicognola, C. et al. Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment. Alzheimers Res. Ther 13, (2021).","DOI":"10.1186\/s13195-021-00804-9"},{"key":"14200_CR8","doi-asserted-by":"crossref","unstructured":"Chatterjee, P. et al. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease. Transl Psychiatry 11, (2021).","DOI":"10.1038\/s41398-020-01137-1"},{"key":"14200_CR9","unstructured":"Benedet, A. L. et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol 78, (2021)."},{"key":"14200_CR10","doi-asserted-by":"publisher","unstructured":"Coleman, M. P. & Freeman, M. R. Wallerian degeneration, WldS, and Nmnat. Annual Review of Neuroscience vol. 33 Preprint at (2010). https:\/\/doi.org\/10.1146\/annurev-neuro-060909-153248","DOI":"10.1146\/annurev-neuro-060909-153248"},{"key":"14200_CR11","unstructured":"Bozzali, M., Cercignani, M., Sormani, M. P., Comi, G. & Filippi, M. Quantification of brain Gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. Am. J. Neuroradiol. 23, (2002)."},{"key":"14200_CR12","doi-asserted-by":"crossref","unstructured":"Pierpaoli, C. & Basser, P. J. Toward a quantitative assessment of diffusion anisotropy. Magn Reson. Med 36, (1996).","DOI":"10.1002\/mrm.1910360612"},{"key":"14200_CR13","doi-asserted-by":"crossref","unstructured":"Basser, P. J., Mattiello, J. & LeBihan, D. MR diffusion tensor spectroscopy and imaging. Biophys J 66, (1994).","DOI":"10.1016\/S0006-3495(94)80775-1"},{"key":"14200_CR14","doi-asserted-by":"crossref","unstructured":"Raghavan, S. et al. Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition. Brain Commun 3, (2021).","DOI":"10.1093\/braincomms\/fcab106"},{"key":"14200_CR15","doi-asserted-by":"publisher","unstructured":"Assaf, Y. & Pasternak, O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: A review. J. Mole. Neurosci. vol. 34 Preprint at (2008). https:\/\/doi.org\/10.1007\/s12031-007-0029-0","DOI":"10.1007\/s12031-007-0029-0"},{"key":"14200_CR16","doi-asserted-by":"crossref","unstructured":"Pasternak, O., Sochen, N., Gur, Y., Intrator, N. & Assaf, Y. Free water elimination and mapping from diffusion MRI. Magn Reson. Med 62, (2009).","DOI":"10.1002\/mrm.22055"},{"key":"14200_CR17","doi-asserted-by":"crossref","unstructured":"Ofori, E. et al. Free-water imaging of the hippocampus is a sensitive marker of Alzheimer\u2019s disease. Neuroimage Clin 24, (2019).","DOI":"10.1016\/j.nicl.2019.101985"},{"key":"14200_CR18","doi-asserted-by":"crossref","unstructured":"Pasternak, O., Shenton, M. E. &amp; Westin, C. F. Estimation of extracellular volume from regularized multi-shell diffusion MRI. in Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) vol. 7511 LNCS (2012).","DOI":"10.1007\/978-3-642-33418-4_38"},{"key":"14200_CR19","doi-asserted-by":"publisher","unstructured":"Kamagata, K. et al. Advanced diffusion magnetic resonance imaging in patients with Alzheimer\u2019s and Parkinson\u2019s diseases. Neural Regener. Res. 15 Preprint at (2020). https:\/\/doi.org\/10.4103\/1673-5374.276326","DOI":"10.4103\/1673-5374.276326"},{"key":"14200_CR20","doi-asserted-by":"publisher","unstructured":"Calsolaro, V. & Edison, P. Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions. Alzheimer\u2019s and Dementia vol. 12 Preprint at (2016). https:\/\/doi.org\/10.1016\/j.jalz.2016.02.010","DOI":"10.1016\/j.jalz.2016.02.010"},{"key":"14200_CR21","doi-asserted-by":"publisher","unstructured":"Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat. Rev. Neurol. vol. 17 Preprint at (2021). https:\/\/doi.org\/10.1038\/s41582-020-00435-y","DOI":"10.1038\/s41582-020-00435-y"},{"key":"14200_CR22","doi-asserted-by":"publisher","unstructured":"Onyango, I. G., Jauregui, G. V., \u010carn\u00e1, M., Bennett, J. P. & Stokin, G. B. Neuroinflammation in Alzheimer\u2019s disease. Biomedicines vol. 9 Preprint at (2021). https:\/\/doi.org\/10.3390\/biomedicines9050524","DOI":"10.3390\/biomedicines9050524"},{"key":"14200_CR23","doi-asserted-by":"publisher","unstructured":"Jang, H. et al. Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD): A Cohort for Dementia Research and Ethnic-Specific Insights. Dement Neurocogn Disord. 23(4), 212\u2013223 https:\/\/doi.org\/10.12779\/dnd.2024.23.4.212","DOI":"10.12779\/dnd.2024.23.4.212"},{"key":"14200_CR24","doi-asserted-by":"crossref","unstructured":"Petersen, R. C. Clinical practice. Mild cognitive impairment. - supplementary data. N Engl. J. Med 364, (2011).","DOI":"10.1056\/NEJMcp0910237"},{"key":"14200_CR25","doi-asserted-by":"crossref","unstructured":"Jeong, H. J. et al. [18F]THK5351 PET imaging in patients with mild cognitive impairment. Journal Clin. Neurol. (Korea) 16, (2020).","DOI":"10.3988\/jcn.2020.16.2.202"},{"key":"14200_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk, W. E. et al. The centiloid project: standardizing quantitative amyloid plaque Estimation by PET. Alzheimer\u2019s Dement. 11, 1\u201315e4 (2015).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14200_CR27","doi-asserted-by":"crossref","unstructured":"Kim, S. J. et al. Development and clinical validation of CT-based regional modified centiloid method for amyloid PET. Alzheimers Res. Ther 14, (2022).","DOI":"10.1186\/s13195-022-01099-0"},{"key":"14200_CR28","doi-asserted-by":"crossref","unstructured":"Cho, S. H. et al. A new centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB. Eur J. Nucl. Med. Mol. Imaging 47, (2020).","DOI":"10.1007\/s00259-020-04692-3"},{"key":"14200_CR29","unstructured":"Ivanov, O. et al. The CIVET image-processing environment: A fully automated comprehensive pipeline for anatomical neuroimaging research yasser references & credits. Proceedings of the 12th annual meeting of the organization for human brain mappin 17, (2005)."},{"key":"14200_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","volume":"18","author":"DL Collins","year":"1994","unstructured":"Collins, D. L., Neelin, P., Peters, T. M. & Evans, A. C. Automatic 3d intersubject registration of Mr volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 18, 192\u2013205 (1994).","journal-title":"J. Comput. Assist. Tomogr"},{"key":"14200_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1109\/42.668698","volume":"17","author":"JG Sled","year":"1998","unstructured":"Sled, J. G. & Zijdenbos, P. Evans, a C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging. 17, 87\u201397 (1998).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"14200_CR32","doi-asserted-by":"crossref","unstructured":"Zijdenbos, A., Forghani, R. &amp; Evans, A. Automatic quantification of MS lesions in 3D mri brain data sets: Validation of INSECT. in Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) vol. 1496 (1998).","DOI":"10.1007\/BFb0056229"},{"key":"14200_CR33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.neuroimage.2005.03.036","volume":"27","author":"SK June","year":"2005","unstructured":"June, S. K. et al. Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a laplacian map and partial volume effect classification. Neuroimage 27, 210\u2013221 (2005).","journal-title":"Neuroimage"},{"key":"14200_CR34","doi-asserted-by":"crossref","unstructured":"Kim, J. et al. Prediction of Tau accumulation in prodromal Alzheimer\u2019s disease using an ensemble machine learning approach. Sci Rep 11, (2021).","DOI":"10.1038\/s41598-021-85165-x"},{"key":"14200_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2013.04.008","author":"K Kwak","year":"2013","unstructured":"Kwak, K. et al. Fully-automated approach to hippocampus segmentation using a graph-cuts algorithm combined with atlas-based segmentation and morphological opening. Magn. Reson. Imaging. https:\/\/doi.org\/10.1016\/j.mri.2013.04.008 (2013).","journal-title":"Magn. Reson. Imaging"},{"key":"14200_CR36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W. & Smith, S. M. Fsl Neuroimage 62, 782\u2013790 (2012).","journal-title":"Fsl Neuroimage"},{"key":"14200_CR37","doi-asserted-by":"crossref","unstructured":"Garyfallidis, E. et al. Dipy, a library for the analysis of diffusion MRI data. Front Neuroinform 8, (2014).","DOI":"10.3389\/fninf.2014.00008"},{"key":"14200_CR38","doi-asserted-by":"crossref","unstructured":"Smith, S. M. et al. Tract-based Spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31, (2006).","DOI":"10.1016\/j.neuroimage.2006.02.024"},{"key":"14200_CR39","doi-asserted-by":"crossref","unstructured":"Ball, G. et al. Development of cortical microstructure in the preterm human brain. Proc Natl. Acad. Sci. U S A 110, (2013).","DOI":"10.1073\/pnas.1301652110"},{"key":"14200_CR40","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Brady, M. & Smith, S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 20, (2001).","DOI":"10.1109\/42.906424"},{"key":"14200_CR41","doi-asserted-by":"crossref","unstructured":"Ashton, N. J. et al. Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring. Nat Med 28, (2022).","DOI":"10.1038\/s41591-022-02074-w"},{"key":"14200_CR42","doi-asserted-by":"publisher","first-page":"1380237","DOI":"10.3389\/fnagi.2024.1380237","volume":"16","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Biofluid biomarkers for Alzheimer\u2019s disease. Front. Aging Neurosci. 16, 1380237 (2024).","journal-title":"Front. Aging Neurosci."},{"key":"14200_CR43","doi-asserted-by":"publisher","first-page":"25419","DOI":"10.1038\/s41598-024-75406-0","volume":"14","author":"R Sattarov","year":"2024","unstructured":"Sattarov, R. et al. Phosphorylated Tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer\u2019s disease: A pilot study. Sci. Rep. 14, 25419 (2024).","journal-title":"Sci. Rep."},{"key":"14200_CR44","unstructured":"Heneka, M. T. et al. Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: A systematic literature review. Mol Psychiatry 1\u201316 (2025)."},{"key":"14200_CR45","doi-asserted-by":"crossref","unstructured":"Ji, F. et al. Associations of blood cardiovascular biomarkers with brain free water and its relationship to cognitive decline: A Diffusion-MRI study. Neurology 101, (2023).","DOI":"10.1212\/WNL.0000000000207401"},{"key":"14200_CR46","doi-asserted-by":"crossref","unstructured":"Nakaya, M. et al. Free water derived by multi-shell diffusion MRI reflects tau\/neuroinflammatory pathology in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia: Translational Res. Clin. Interventions 8, (2022).","DOI":"10.1002\/trc2.12356"},{"key":"14200_CR47","doi-asserted-by":"crossref","unstructured":"Dumont, M. et al. Free water in white matter differentiates MCI and AD from control subjects. Front Aging Neurosci 11, (2019).","DOI":"10.3389\/fnagi.2019.00270"},{"key":"14200_CR48","doi-asserted-by":"crossref","unstructured":"Hoy, A. R. et al. Microstructural white matter alterations in preclinical Alzheimer\u2019s disease detected using free water elimination diffusion tensor imaging. PLoS One 12, (2017).","DOI":"10.1371\/journal.pone.0173982"},{"key":"14200_CR49","doi-asserted-by":"crossref","unstructured":"Alexander, A. L., Lee, J. E., Lazar, M. & Field, A. S. Diffus. Tensor Imaging Brain Neurotherapeutics 4, (2007).","DOI":"10.1016\/j.nurt.2007.05.011"},{"key":"14200_CR50","doi-asserted-by":"crossref","unstructured":"Spotorno, N. et al. Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer\u2019s disease. Brain 147, (2024).","DOI":"10.1093\/brain\/awad428"},{"key":"14200_CR51","doi-asserted-by":"publisher","unstructured":"Zhang, B., Xu, Y., Zhu, B. & Kantarci, K. The role of diffusion tensor imaging in detecting microstructural changes in prodromal Alzheimer\u2019s disease. CNS Neuroscience and Therapeutics vol. 20 Preprint at (2014). https:\/\/doi.org\/10.1111\/cns.12166","DOI":"10.1111\/cns.12166"},{"key":"14200_CR52","doi-asserted-by":"crossref","unstructured":"van Uden, I. W. M. et al. Diffusion tensor imaging of the hippocampus predicts the risk of dementia, the RUN DMC study. Hum Brain Mapp 37, (2016).","DOI":"10.1002\/hbm.23029"},{"key":"14200_CR53","doi-asserted-by":"publisher","unstructured":"Raff, M. C., Whitmore, A. V., Finn, J. T. & Neuroscience Axonal self-destruction and neurodegeneration. Science vol. 296 Preprint at (2002). https:\/\/doi.org\/10.1126\/science.1068613","DOI":"10.1126\/science.1068613"},{"key":"14200_CR54","doi-asserted-by":"crossref","unstructured":"Pasternak, O., Westin, C. F., Dahlben, B., Bouix, S. & Kubicki, M. The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia. Schizophr Res 161, (2015).","DOI":"10.1016\/j.schres.2014.07.031"},{"key":"14200_CR55","doi-asserted-by":"publisher","unstructured":"Bronzuoli, M. R., Iacomino, A., Steardo, L. & Scuderi, C. Targeting neuroinflammation in Alzheimer\u2019s disease. J. Inflamm. Res. vol. 9 Preprint at (2016). https:\/\/doi.org\/10.2147\/JIR.S86958","DOI":"10.2147\/JIR.S86958"},{"key":"14200_CR56","doi-asserted-by":"publisher","unstructured":"Adamu, A., Li, S., Gao, F. & Xue, G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front. Aging Neurosci. vol. 16 Preprint at (2024). https:\/\/doi.org\/10.3389\/fnagi.2024.1347987","DOI":"10.3389\/fnagi.2024.1347987"},{"key":"14200_CR57","doi-asserted-by":"publisher","unstructured":"Jung, Y. J., Tweedie, D., Scerba, M. T. & Greig, N. H. Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments. Frontiers in Cell and Developmental Biology vol. 7 Preprint at (2019). https:\/\/doi.org\/10.3389\/fcell.2019.00313","DOI":"10.3389\/fcell.2019.00313"},{"key":"14200_CR58","doi-asserted-by":"crossref","unstructured":"Kurki, S. N. et al. Acute neuroinflammation leads to disruption of neuronal chloride regulation and consequent hyperexcitability in the dentate gyrus. Cell Rep 42, (2023).","DOI":"10.2139\/ssrn.4425877"},{"key":"14200_CR59","doi-asserted-by":"publisher","unstructured":"Zhang, W., Xiao, D., Mao, Q. & Xia, H. Role of neuroinflammation in neurodegeneration development. Signal Transduct.Targeted Therapy vol. 8 Preprint at (2023). https:\/\/doi.org\/10.1038\/s41392-023-01486-5","DOI":"10.1038\/s41392-023-01486-5"},{"key":"14200_CR60","doi-asserted-by":"crossref","unstructured":"Hoy, A. R., Koay, C. G., Kecskemeti, S. R. & Alexander, A. L. Optimization of a free water elimination two-compartment model for diffusion tensor imaging. Neuroimage 103, (2014).","DOI":"10.1016\/j.neuroimage.2014.09.053"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14200-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14200-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14200-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:08:05Z","timestamp":1757441285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14200-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14200"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14200-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Samsung Medical Center approved this study (No. 2021-02-135). All participants provided their informed consent to participate in the study, and all methods were in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Henrik Zetterberg has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has delivered lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work).Kaj Blennow has served as a consultant and on advisory boards for Abbvie, AC Immune, ALZPath, AriBio, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Novartis, Ono Pharma, Prothena, Roche Diagnostics, and Siemens Healthineers; has served on data monitoring committees for Julius Clinical and Novartis; has delivered lectures, produced educational materials, and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. All other authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30702"}}